138 related articles for article (PubMed ID: 38385385)
1. Efficacy of mTOR Inhibitors and Intravenous Immunoglobulin for Treatment of Polyoma BK Nephropathy in Kidney Transplant Recipients: A Biopsy-Proven Study.
Karatas M; Tatar E; Okut G; Yildirim AM; Kocabas E; Tasli Alkan F; Simsek C; Dogan SM; Uslu A
Exp Clin Transplant; 2024 Jan; 22(Suppl 1):118-127. PubMed ID: 38385385
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
Shah T; Vu D; Naraghi R; Campbell A; Min D
Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
[TBL] [Abstract][Full Text] [Related]
3. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
[TBL] [Abstract][Full Text] [Related]
4. Predictive Factors of BK Virus Development in Kidney Transplant Recipients and the Effect of Low-Dose Tacrolimus Plus Everolimus on Clinical Outcomes.
Yilmaz VT; Kisaoglu A; Avanaz A; Dandin O; Ozel D; Mutlu D; Akkaya B; Aydinli B; Kocak H
Exp Clin Transplant; 2023 Sep; 21(9):727-734. PubMed ID: 37885288
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
6. Treatment of BK Polyomavirus-Associated Nephropathy in Paediatric Kidney Transplant Recipients: Leflunomide Versus Cidofovir.
Kaya Aksoy G; Erkan M; Koyun M; Çomak E; Toru HS; Mutlu D; Akkaya B; Akman S
Exp Clin Transplant; 2024 Jan; 22(1):29-34. PubMed ID: 38149668
[TBL] [Abstract][Full Text] [Related]
7. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
Westphal SG; Lyden ER; Langewisch ED; Miles CD
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
[TBL] [Abstract][Full Text] [Related]
8. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.
Vu D; Shah T; Ansari J; Naraghi R; Min D
Transplant Proc; 2015 Mar; 47(2):394-8. PubMed ID: 25769580
[TBL] [Abstract][Full Text] [Related]
10. Do Antithymocyte Globulin-Free Acute Rejection Therapies Increase the Risk of Polyoma Nephropathy in Renal Transplant Recipients?
Günay E; Zeytinoğlu A; Şen S; Yılmaz M; Atay G; Aşcı G; Sezer TO; Töz H
Transplant Proc; 2019 May; 51(4):1112-1114. PubMed ID: 31101182
[TBL] [Abstract][Full Text] [Related]
11. IVIg therapy in the management of BK virus infections in pediatric kidney transplant patients.
Mosca M; Bacchetta J; Chamouard V; Rascle P; Dubois V; Paul S; Mekki Y; Picard C; Bertholet-Thomas A; Ranchin B; Sellier-Leclerc AL
Arch Pediatr; 2023 Apr; 30(3):165-171. PubMed ID: 36907728
[TBL] [Abstract][Full Text] [Related]
12. BIOPSY-PROVEN BK VIRUS NEPHROPATHY WITHOUT DETECTABLE BK VIREMIA IN A ONE-YEAR POST-KIDNEY TRANSPLANT RECIPIENT.
Ruangkanchanasetr P; Pumchandh N; Satirapoj B; Termmathurapoj S; Pongthanapisith V
Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):657-61. PubMed ID: 26867385
[TBL] [Abstract][Full Text] [Related]
13. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
Pape L; Tönshoff B; Hirsch HH;
Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
[TBL] [Abstract][Full Text] [Related]
14. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
16. [Oscillation between BK virus nephropathy and rejection--the frustrating course of a living donor transplantation].
Materne C; Gerth J; Ott U; Gröne HJ; Wolf G
Med Klin (Munich); 2009 Aug; 104(8):644-8. PubMed ID: 19701735
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
Ji J; Feng S; Jiang Y; Wang W; Zhang X
Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
[TBL] [Abstract][Full Text] [Related]
18. Comparative Study of Intravenous Immunoglobulin and Leflunomide Combination Therapy With Intravenous Immunoglobulin Single Therapy in Kidney Transplant Patients With BK Virus Infection: Single-Center Clinical Trial.
Rasaei N; Malekmakan L; Gholamabbas G; Abdizadeh P
Exp Clin Transplant; 2023 Oct; 21(10):814-819. PubMed ID: 37965956
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic and therapeutic dilemma of the co-existence of BK virus nephropathy with acute rejection - an experience from a single Centre and review of the literature.
Shanmugham S; Bhadauria D; Agrawal V; Jain M; Yaccha M; Kaul A; Vamsidhar V; Meyyappan J; Prasad N
Transpl Immunol; 2022 Jun; 72():101581. PubMed ID: 35301106
[TBL] [Abstract][Full Text] [Related]
20. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy.
Masutani K; Tsuchimoto A; Matsukuma Y; Kurihara K; Nishiki T; Kitada H; Tanaka M; Kitazono T; Tsuruya K
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():45-50. PubMed ID: 26031586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
